Parkinsonian syndromes are a heterogeneous group of progressive neurodegenerative
disorders involving the nigrostriatal dopaminergic pathway and are characterized by a wide …

Background Diagnosing Dementia with Lewy Bodies (DLB) remains a challenge in clinical
practice. The use of 123I-ioflupane (DaTscan™) SPECT imaging, which detects reduced …

Purpose Dopamine transporter (DAT) imaging is used to support the diagnosis of
neurodegenerative parkinsonian disorders. Specific medications have been reported to …

Purpose Presynaptic dopaminergic positron emission tomography (PET) imaging serves as
an essential tool in diagnosing and differentiating patients with suspected parkinsonism …

Objective This study was undertaken to investigate the effects of dietary caffeine intake on
striatal dopamine function and clinical symptoms in Parkinson disease in a cross‐sectional …

Abstract N-3-[18F] fluoropropyl-2β-carbomethoxy-3β-4-iodophenyl nortropane ([18F] FP-
CIT) is a radiopharmaceutical for dopamine transporter (DAT) imaging using positron …

Background As the diagnosis of Parkinson's disease (PD) is fundamentally clinical, the
usefulness of ioflupane (123I) single‐photon emission computed tomography (SPECT) or …

Purpose [123 I] I-FP-CIT SPECT is an imaging tool to support the diagnosis of parkinsonian
syndromes characterized by nigrostriatal dopaminergic degeneration. After intravenous …

Objectives The authors describe five depressive patients with initially decreased striatal
accumulation of dopamine transporter (DAT) single-photon emission computed tomography …

Aim This study aimed to clarify the abnormalities in dopamine transporter (DAT) availability
in drug‐naive adult patients with attention‐deficit/hyperactivity disorder (ADHD) and the …